RhumbLine Advisers’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15M | Buy |
778,957
+31,108
| +4% | +$613K | 0.01% | 861 |
|
|
2025
Q4 | $14.2M | Sell |
747,849
-76,228
| -9% | -$1.41M | 0.01% | 898 |
|
|
2025
Q3 | $15.4M | Sell |
824,077
-50,284
| -6% | -$939K | 0.01% | 878 |
|
|
2025
Q2 | $16.1M | Buy |
874,361
+29,846
| +4% | +$530K | 0.01% | 820 |
|
|
2025
Q1 | $14.8M | Sell |
844,515
-6,963
| -0.8% | -$117K | 0.01% | 848 |
|
|
2024
Q4 | $14.7M | Buy |
851,478
+17,823
| +2% | +$325K | 0.01% | 864 |
|
|
2024
Q3 | $15.5M | Sell |
833,655
-19,811
| -2% | -$334K | 0.01% | 858 |
|
|
2024
Q2 | $13.1M | Buy |
853,466
+2,930
| +0.3% | +$41.9K | 0.01% | 898 |
|
|
2024
Q1 | $12.6M | Buy |
850,536
+13,989
| +2% | +$194K | 0.01% | 940 |
|
|
2023
Q4 | $11.9M | Sell |
836,547
-22,048
| -3% | -$313K | 0.01% | 967 |
|
|
2023
Q3 | $12M | Sell |
858,595
-6,464
| -0.7% | -$82.7K | 0.01% | 898 |
|
|
2023
Q2 | $10.2M | Buy |
865,059
+185
| +0% | +$2.11K | 0.01% | 1002 |
|
|
2023
Q1 | $9.95M | Buy |
864,874
+8,055
| +0.9% | +$99.6K | 0.01% | 967 |
|
|
2022
Q4 | $10.7M | Buy |
856,819
+11,281
| +1% | +$144K | 0.01% | 908 |
|
|
2022
Q3 | $11.1M | Buy |
845,538
+26,983
| +3% | +$399K | 0.02% | 838 |
|
|
2022
Q2 | $11.4M | Buy |
818,555
+73,009
| +10% | +$976K | 0.02% | 834 |
|
|
2022
Q1 | $11.1M | Sell |
745,546
-17,172
| -2% | -$235K | 0.01% | 898 |
|
|
2021
Q4 | $10.3M | Buy |
762,718
+30,340
| +4% | +$429K | 0.01% | 969 |
|
|
2021
Q3 | $10.8M | Buy |
732,378
+6,852
| +0.9% | +$116K | 0.01% | 915 |
|
|
2021
Q2 | $13.2M | Buy |
725,526
+838
| +0.1% | +$14.9K | 0.02% | 839 |
|
|
2021
Q1 | $12.6M | Sell |
724,688
-13,644
| -2% | -$240K | 0.02% | 851 |
|
|
2020
Q4 | $12.8M | Buy |
738,332
+24,179
| +3% | +$386K | 0.02% | 783 |
|
|
2020
Q3 | $9.85M | Sell |
714,153
-97,293
| -12% | -$1.43M | 0.02% | 783 |
|
|
2020
Q2 | $11.7M | Buy |
811,446
+18,701
| +2% | +$246K | 0.02% | 690 |
|
|
2020
Q1 | $8.66M | Buy |
792,745
+35,245
| +5% | +$650K | 0.02% | 721 |
|
|
2019
Q4 | $16.2M | Buy |
757,500
+34,531
| +5% | +$773K | 0.03% | 583 |
|
|
2019
Q3 | $16.6M | Buy |
722,969
+32,890
| +5% | +$702K | 0.03% | 526 |
|
|
2019
Q2 | $13.6M | Buy |
690,079
+79,663
| +13% | +$1.55M | 0.03% | 623 |
|
|
2019
Q1 | $11.9M | Sell |
610,416
-50,449
| -8% | -$956K | 0.02% | 675 |
|
|
2018
Q4 | $10.9M | Buy |
660,865
+304,911
| +86% | +$6.14M | 0.02% | 662 |
|
|
2018
Q3 | $8.23M | Sell |
355,954
-3,943
| -1% | -$89.3K | 0.02% | 787 |
|
|
2018
Q2 | $7.82M | Buy |
359,897
+8,536
| +2% | +$167K | 0.02% | 803 |
|
|
2018
Q1 | $6.2M | Sell |
351,361
-12,796
| -4% | -$226K | 0.01% | 908 |
|
|
2017
Q4 | $6.83M | Sell |
364,157
-43,616
| -11% | -$868K | 0.01% | 882 |
|
|
2017
Q3 | $8.95M | Buy |
407,773
+264,195
| +184% | +$5.97M | 0.02% | 727 |
|
|
2017
Q2 | $3.46M | Sell |
143,578
-15,978
| -10% | -$406K | 0.01% | 1223 |
|
|
2017
Q1 | $4.46M | Buy |
159,556
+56,270
| +54% | +$1.48M | 0.01% | 1075 |
|
|
2016
Q4 | $2.52M | Buy |
103,286
+1,805
| +2% | +$41.4K | 0.01% | 1308 |
|
|
2016
Q3 | $2.56M | Buy |
101,481
+5,425
| +6% | +$130K | 0.01% | 1255 |
|
|
2016
Q2 | $1.98M | Sell |
96,056
-16,854
| -15% | -$351K | 0.01% | 1349 |
|
|
2016
Q1 | $2.27M | Buy |
112,910
+10,480
| +10% | +$201K | 0.01% | 1289 |
|
|
2015
Q4 | $2.07M | Buy |
102,430
+4,565
| +5% | +$96.1K | 0.01% | 1332 |
|
|
2015
Q3 | $2.27M | Buy |
97,865
+9,401
| +11% | +$240K | 0.01% | 1247 |
|
|
2015
Q2 | $2.28M | Buy |
88,464
+16,355
| +23% | +$464K | 0.01% | 1308 |
|
|
2015
Q1 | $2.39M | Buy |
72,109
+13,160
| +22% | +$427K | 0.01% | 1282 |
|
|
2014
Q4 | $1.79M | Buy |
58,949
+5,425
| +10% | +$150K | 0.01% | 1426 |
|
|
2014
Q3 | $1.3M | Sell |
53,524
-675
| -1% | -$18.7K | ﹤0.01% | 1584 |
|
|
2014
Q2 | $1.56M | Sell |
54,199
-1,472
| -3% | -$42.8K | ﹤0.01% | 1541 |
|
|
2014
Q1 | $1.55M | Sell |
55,671
-2,164
| -4% | -$59.4K | ﹤0.01% | 1511 |
|
|
2013
Q4 | $1.51M | Sell |
57,835
-540
| -0.9% | -$13.9K | ﹤0.01% | 1538 |
|
|
2013
Q3 | $1.34M | Hold |
58,375
| – | – | ﹤0.01% | 1581 |
|
|
2013
Q2 | $1.52M | Buy |
+58,375
| New | +$1.68M | ﹤0.01% | 1495 |
|
Other funds holding SBRA
VPM
VCM
N
RhumbLine Advisers's SBRA Position: Q1 2026 in Review
RhumbLine Advisers increased its Sabra Healthcare REIT (SBRA) stake by 4.2% in Q1 2026, buying an estimated $613K and bringing the position to 778,957 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #861.
RhumbLine Advisers first reported a position in SBRA in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.6M in Q3 2019. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- RhumbLine Advisers held 778,957 shares of Sabra Healthcare REIT worth $15M as of Q1 2026.
- RhumbLine Advisers bought 31,108 Sabra Healthcare REIT shares in Q1 2026, an estimated $613K.
- Sabra Healthcare REIT made up 0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #861 holding.
- RhumbLine Advisers first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 52 quarters since.
- RhumbLine Advisers's Sabra Healthcare REIT position peaked at $16.6M in Q3 2019.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.